Methocarbamol

This classification denotes a muscle relaxant with the molecular formula C11H15NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 125OD7737X, chemically known as 1,2-propanediol, 3-(o-methoxyphenoxy)-, 1-carbamate but generally known as methocarbamol, which bears US NIH Compound Identifier 4107. European Medicines Agency schedules Methocarbamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08852MIG. The term METHOCARBAMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methocarbamol in its Anatomical Therapeutic Chemical (ATC) Classification. METHOCARBAMOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methocarbamol under HS 29242995 and SITC 51479. As of Q4 2014, METHOCARBAMOL remains the US FDA Preferred Term for this commodity. Methocarbamol bears US NLM identifiers UMLS ID C0025659 and NCI Concept Code C29252. SMILES: COC1=CC=CC=C1OCC(COC(=O)N)O.